Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

SH Noh, SR Park, HK Yang, HC Chung… - The lancet …, 2014 - thelancet.com
Background The CLASSIC trial was done to compare adjuvant capecitabine plus oxaliplatin
versus observation after D2 gastrectomy for patients with stage II or III gastric cancer. The …
被引用次数：1017 相关文章 所有 13 个版本
[PDF] cinj.org

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

YJ Bang, YW Kim, HK Yang, HC Chung, YK Park… - The Lancet, 2012 - thelancet.com
Background D2 gastrectomy is recommended in US and European guidelines, and is
preferred in east Asia, for patients with resectable gastric cancer. Adjuvant chemotherapy …
被引用次数：1913 相关文章 所有 25 个版本
[PDF] springer.com

Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study

N Fuse, H Bando, K Chin, S Ito, T Yoshikawa… - Gastric Cancer, 2017 - Springer
Background Adjuvant chemotherapy with XELOX (capecitabine plus oxaliplatin) has been
shown to be beneficial following resection of gastric cancer in South Korean, Chinese, and …
被引用次数：78 相关文章 所有 17 个版本
[HTML] sciencedirect.com

[HTML][HTML] Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in …

J Ji, L Shen, Z Li, X Zhang, H Liang, Y Xue, Y Wang… - Annals of …, 2019 - Elsevier
Background Surgery alone is not sufficient to achieve satisfactory prognosis for locally
advanced gastric cancer (LAGC), and perioperative therapies have been proposed to …
被引用次数：59 相关文章 所有 2 个版本

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro …

X Zhang, H Liang, Z Li, Y Xue, Y Wang, Z Zhou… - The Lancet …, 2021 - thelancet.com
Background The optimal perioperative chemotherapeutic regimen for locally advanced
gastric cancer remains undefined. We evaluated the efficacy and safety of perioperative and …
被引用次数：247 相关文章 所有 6 个版本
[PDF] niioncologii.ru

Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant …

SH Park, TS Sohn, J Lee, DH Lim, ME Hong… - Journal of clinical …, 2015 - ascopubs.org
Purpose The Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) trial tested whether
the addition of radiotherapy to adjuvant chemotherapy improved disease-free survival (DFS) …
被引用次数：473 相关文章 所有 11 个版本
[PDF] springer.com

Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy

K Shitara, K Chin, T Yoshikawa, H Katai, M Terashima… - Gastric Cancer, 2017 - Springer
Abstract Background The Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer (ACTS-GC)
demonstrated a survival benefit by adjuvant S-1 monotherapy in patients who had …
被引用次数：98 相关文章 所有 13 个版本
[PDF] academia.edu

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer …

J Lee, DH Lim, S Kim, SH Park, JO Park… - Journal of clinical …, 2012 - ascopubs.org
Purpose The ARTIST (Adjuvant Chemoradiation Therapy in Stomach Cancer) trial was the
first study to our knowledge to investigate the role of postoperative chemoradiotherapy …
被引用次数：958 相关文章 所有 9 个版本
[HTML] sciencedirect.com

[HTML][HTML] Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial

WO De Steur, RM van Amelsfoort, HH Hartgrink… - Annals of …, 2021 - Elsevier
Background The Intergroup 0116 and the MAGIC trials changed clinical practice for
resectable gastric cancer in the Western world. In these trials, overall survival improved with …
被引用次数：62 相关文章 所有 8 个版本
[HTML] sciencedirect.com

[HTML][HTML] Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial …

O Bouche, M Ychou, P Burtin, L Bedenne, M Ducreux… - Annals of …, 2005 - Elsevier
Background: The aim of this study was to evaluate the efficacy of adjuvant chemotherapy
after resection for gastric cancer in a randomized controlled trial. Patients and methods: After …
被引用次数：198 相关文章 所有 13 个版本